Literature DB >> 21143034

Facile synthesis of water-stable magnetite nanoparticles for clinical MRI and magnetic hyperthermia applications.

Dipak Maity1, Prashant Chandrasekharan, Chang-Tong Yang, Kai-Hsiang Chuang, Borys Shuter, Jun-Min Xue, Jun Ding, Si-Shen Feng.   

Abstract

AIMS: Superparamagnetic magnetite nanoparticles have been under intensive investigation in nanomedicine. However, it is still a challenge to synthesize high-quality water-stable magnetite nanoparticles for better magnetic performance and less side effects in medical MRI and nanothermotherapy. MATERIALS &
METHODS: We successfully synthesized hydrophilic magnetite nanoparticles through thermal decomposition of Fe(acac)(3) in triethylene glycol, which were coated with a triethylene glycol layer and thus demonstrated excellent water stability.
RESULTS: The optimized deposition temperature has been found to be 250°C (IO-250 NPs). The magnetic and thermal properties as well as the cytotoxicity of IO-250 NPs were investigated. In vitro experiments have demonstrated high cellular uptake and low cytotoxicity. The hyperthermia experiments showed effectiveness in temperature rise and cancer cell death. IO-250 NPs showed promising MRI with relaxivity r(2)* as high as 617.5 s(-1) mM(-1) Fe. In vivo MRI showed excellent tumor imaging.
CONCLUSION: The IO-250 NPs have great potential to be applied for clinical MRI and magnetic thermotherapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21143034     DOI: 10.2217/nnm.10.77

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  8 in total

1.  Preparation, characterization of 2-deoxy-D-glucose functionalized dimercaptosuccinic acid-coated maghemite nanoparticles for targeting tumor cells.

Authors:  Fei Xiong; Zi-yi Zhu; Chen Xiong; Xiao-qing Hua; Xiu-hong Shan; Yu Zhang; Ning Gu
Journal:  Pharm Res       Date:  2011-12-16       Impact factor: 4.200

2.  Synthesis, characterization and in vitro biocompatibility study of Au/TMC/Fe3O4 nanocomposites as a promising, nontoxic system for biomedical applications.

Authors:  Hanieh Shirazi; Maryam Daneshpour; Soheila Kashanian; Kobra Omidfar
Journal:  Beilstein J Nanotechnol       Date:  2015-08-03       Impact factor: 3.649

3.  Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy.

Authors:  Tianyuzi Li; Howard E Gendelman; Gang Zhang; Pavan Puligujja; JoEllyn M McMillan; Tatiana K Bronich; Benson Edagwa; Xin-Ming Liu; Michael D Boska
Journal:  Int J Nanomedicine       Date:  2015-06-03

Review 4.  Recent Nanotechnology Approaches for Prevention and Treatment of Biofilm-Associated Infections on Medical Devices.

Authors:  Mohankandhasamy Ramasamy; Jintae Lee
Journal:  Biomed Res Int       Date:  2016-10-31       Impact factor: 3.411

5.  Ultrasmall superparamagnetic Fe3O4 nanoparticles: honey-based green and facile synthesis and in vitro viability assay.

Authors:  Elisa Rasouli; Wan Jeffrey Basirun; Majid Rezayi; Kamyar Shameli; Esmail Nourmohammadi; Roshanak Khandanlou; Zahra Izadiyan; Hoda Khoshdel Sarkarizi
Journal:  Int J Nanomedicine       Date:  2018-10-26

6.  Functionalized Hydrophilic Superparamagnetic Iron Oxide Nanoparticles for Magnetic Fluid Hyperthermia Application in Liver Cancer Treatment.

Authors:  Ganeshlenin Kandasamy; Atul Sudame; Tania Luthra; Kalawati Saini; Dipak Maity
Journal:  ACS Omega       Date:  2018-04-10

Review 7.  Nanomaterial Probes for Nuclear Imaging.

Authors:  Vanessa Jing Xin Phua; Chang-Tong Yang; Bin Xia; Sean Xuexian Yan; Jiang Liu; Swee Eng Aw; Tao He; David Chee Eng Ng
Journal:  Nanomaterials (Basel)       Date:  2022-02-09       Impact factor: 5.076

Review 8.  Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics.

Authors:  Wensheng Xie; Zhenhu Guo; Fei Gao; Qin Gao; Dan Wang; Bor-Shuang Liaw; Qiang Cai; Xiaodan Sun; Xiumei Wang; Lingyun Zhao
Journal:  Theranostics       Date:  2018-05-11       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.